DRUG ADMINISTERED AT INAPPROPRIATE SITE

This adverse event was reported 10556 times

These drugs are most commonly taken by patients reporting DRUG ADMINISTERED AT INAPPROPRIATE SITE:

# Drug Count
0 DICLOFENAC SODIUM 1841
1 METHYLPHENIDATE 680
2 MINOXIDIL 500
3 BUPRENORPHINE 404
4 ADALIMUMAB 325
5 INTERFERON BETA-1A 236
6 OXYBUTYNIN 192
7 ASPIRIN 173
8 ERGOCALCIFEROL 169
9 ASPIRIN 325 MG 167
See all common drugs associated with DRUG ADMINISTERED AT INAPPROPRIATE SITE

DRUG ADMINISTERED AT INAPPROPRIATE SITE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENZOCAINE AND BENZETHONIUM CHLORIDE 1 0.0556
1 CALCIPOTRIENE CREAM, 0.005% 3 0.0291
2 LUBRICATING EYE DROPS 1 0.0270
3 CLOTRIMAZOLE USP1% 1 0.0263
4 ACYCLOVIR AND HYDROCORTISONE 1 0.0250
5 ZINGIBER OFFICINALE 2 0.0230
6 THYROTROPIN ALFA 23 0.0222
7 KETOCONAZOLE 1% 2 0.0164
8 BUTENAFINE HYDROCHLORIDE 9 0.0151
9 DICLOFENAC SODIUM 1841 0.0121
See all drugs enriched for association with DRUG ADMINISTERED AT INAPPROPRIATE SITE

DRUG ADMINISTERED AT INAPPROPRIATE SITE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Stimulating Hormone [EPC] 23 0.0222
1 Central Nervous System Stimulant [EPC] 694 0.0079
2 Arteriolar Vasodilator [EPC] 554 0.0070
3 Cholinergic Muscarinic Antagonist [EPC] 194 0.0049
4 Partial Opioid Agonist [EPC] 404 0.0043
5 Endoglycosidase [EPC] 6 0.0032
6 Androgen [EPC] 55 0.0020
7 RNA Synthetase Inhibitor Antibacterial [EPC] 27 0.0019
8 Prostaglandin Analog [EPC] 164 0.0018
9 Melanin Synthesis Inhibitor [EPC] 2 0.0018
See all drug classes enriched for association with DRUG ADMINISTERED AT INAPPROPRIATE SITE